Eli Lilly Completes Acquisition of Verve Therapeutics to Advance One-Time Treatments for People with High Cardiovascular Risk

Eli Lilly Acquired Verve Therapeutics

Eli Lilly and Company (LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc. (This content is for paid subscribers.

Please click here to subscribe or here to log in.